Minerva Neurosciences Inc (NERV)
2.41
-0.03
(-1.09%)
USD |
NASDAQ |
Apr 29, 16:00
2.46
+0.05
(+2.07%)
After-Hours: 20:00
Minerva Neurosciences Shareholders Equity (Quarterly): -28.46M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -28.46M |
| September 30, 2023 | -20.05M |
| June 30, 2023 | -12.51M |
| March 31, 2023 | -26.62M |
| December 31, 2022 | -20.02M |
| September 30, 2022 | -14.25M |
| June 30, 2022 | -8.382M |
| March 31, 2022 | -0.7361M |
| December 31, 2021 | 7.976M |
| September 30, 2021 | 28.08M |
| June 30, 2021 | 36.17M |
| March 31, 2021 | 45.37M |
| December 31, 2020 | 52.66M |
| September 30, 2020 | 58.02M |
| June 30, 2020 | 56.94M |
| March 31, 2020 | 18.62M |
| December 31, 2019 | 27.78M |
| September 30, 2019 | 55.53M |
| June 30, 2019 | 67.27M |
| March 31, 2019 | 77.42M |
| December 31, 2018 | 90.26M |
| Date | Value |
|---|---|
| September 30, 2018 | 101.39M |
| June 30, 2018 | 110.66M |
| March 31, 2018 | 121.29M |
| December 31, 2017 | 131.60M |
| September 30, 2017 | 130.18M |
| June 30, 2017 | 98.03M |
| March 31, 2017 | 106.29M |
| December 31, 2016 | 105.98M |
| September 30, 2016 | 113.14M |
| June 30, 2016 | 120.60M |
| March 31, 2016 | 66.65M |
| December 31, 2015 | 55.32M |
| September 30, 2015 | 63.07M |
| June 30, 2015 | 68.38M |
| March 31, 2015 | 74.44M |
| December 31, 2014 | 51.50M |
| September 30, 2014 | 56.72M |
| June 30, 2014 | 29.23M |
| March 31, 2014 | 34.09M |
| December 31, 2013 | 20.18M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-28.46M
Minimum
Dec 2023
67.27M
Maximum
Jun 2019
17.02M
Average
18.62M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics Inc | 933.89M |
| Janux Therapeutics Inc | 344.35M |
| ACADIA Pharmaceuticals Inc | 431.76M |
| Karyopharm Therapeutics Inc | -136.21M |
| Calidi Biotherapeutics Inc | -8.235M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.90M |
| Total Liabilities (Quarterly) | 85.36M |